BOLA2
gene geneOn this page
Also known as My016BOLA2A
Summary
BOLA2 (bolA family member 2, HGNC:29488) is a protein-coding gene on chromosome 16p11.2, encoding BolA-like protein 2 (Q9H3K6). Acts as a cytosolic iron-sulfur (Fe-S) cluster assembly factor that facilitates [2Fe-2S] cluster insertion into a subset of cytosolic proteins.
This gene is located within a region of a segmental duplication on chromosome 16 and is identical to BOLA2B (bolA family member 2B). The product of this gene belongs to a family of proteins that are widely conserved and may be involved in iron maturation. Related pseudogenes are found multiple different chromosomes. Alternative splicing results in multiple transcript variants. Transcripts initiating at this locus may extend into downstream SMG1 pseudogene 6 (SMG1P6) and encode fusion proteins with a C-terminus related to SMG1 phosphatidylinositol 3-kinase-related kinase. A readthrough locus is represented with GeneID:107282092.
Source: NCBI Gene 552900 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 5 total
- Druggable target: yes — 1 molecules with ChEMBL bioactivity
- MANE Select transcript:
NM_001031827
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:29488 |
| Approved symbol | BOLA2 |
| Name | bolA family member 2 |
| Location | 16p11.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | My016, BOLA2A |
| Ensembl gene | ENSG00000183336 |
| Ensembl biotype | protein_coding |
| OMIM | 613182 |
| Entrez | 552900 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 5 protein_coding
ENST00000330978, ENST00000692192, ENST00000856522, ENST00000925511, ENST00000925512
RefSeq mRNA: 3 — MANE Select: NM_001031827
NM_001031827, NM_001320579, NM_001421680
CCDS: CCDS32426
Canonical transcript exons
ENST00000330978 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001806596 | 29453593 | 29453732 |
| ENSE00003592372 | 29454016 | 29454113 |
| ENSE00003718126 | 29454191 | 29454351 |
Expression profiles
Bgee: expression breadth ubiquitous, 131 present calls, max score 87.27.
Top tissues by expression
132 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 87.27 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 81.08 | gold quality |
| monocyte | CL:0000576 | 74.09 | gold quality |
| prefrontal cortex | UBERON:0000451 | 74.07 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 74.01 | gold quality |
| leukocyte | CL:0000738 | 73.76 | gold quality |
| ganglionic eminence | UBERON:0004023 | 73.60 | gold quality |
| cortical plate | UBERON:0005343 | 73.45 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 72.84 | gold quality |
| stromal cell of endometrium | CL:0002255 | 72.76 | gold quality |
| primary visual cortex | UBERON:0002436 | 72.31 | gold quality |
| ventricular zone | UBERON:0003053 | 71.32 | gold quality |
| granulocyte | CL:0000094 | 71.25 | gold quality |
| cortex of kidney | UBERON:0001225 | 70.69 | gold quality |
| duodenum | UBERON:0002114 | 69.74 | gold quality |
| bone marrow cell | CL:0002092 | 69.14 | silver quality |
| bone marrow | UBERON:0002371 | 68.39 | gold quality |
| frontal cortex | UBERON:0001870 | 67.95 | gold quality |
| blood | UBERON:0000178 | 67.80 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 67.66 | gold quality |
| placenta | UBERON:0001987 | 67.50 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 66.51 | gold quality |
| right adrenal gland | UBERON:0001233 | 66.44 | gold quality |
| testis | UBERON:0000473 | 66.38 | gold quality |
| cerebral cortex | UBERON:0000956 | 66.36 | gold quality |
| left coronary artery | UBERON:0001626 | 66.32 | gold quality |
| substantia nigra | UBERON:0002038 | 66.23 | gold quality |
| left testis | UBERON:0004533 | 66.07 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 66.04 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 65.84 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-HCAD-9 | yes | 17.71 |
| E-HCAD-8 | no | 47.56 |
| E-ANND-3 | no | 0.84 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 5)
- This study reported that all three human BolA proteins (hBolA1, hBolA2, and hBolA3) are novel non-classical secreted proteins identified with bioinformatics and molecular biology experiments. (PMID:18548201)
- apo GRX3 and apo BOLA2 form a heterotrimeric complex, composed by two BOLA2 molecules and one GRX3 molecule (PMID:26613676)
- BOLA2 shows Homo sapiens-specific duplication; this occurred around 280,000 years ago, with the duplication nearly fixed early in the human lineage (PMID:27487209)
- The Glrx3 and BolA2 bound and facilitated Fe-S incorporation into Ciapin1, a [2Fe-2S] protein functioning early in the cytosolic Fe-S assembly pathway. Thus, Glrx3.BolA is a [2Fe-2S] chaperone complex capable of transferring [2Fe-2S] clusters to apoproteins in human cells. (PMID:27519415)
- BOLA2 participates in iron homeostasis in vivo. (PMID:31668704)
Cross-species orthologs
6 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | BOLA2B | ENSDARG00000111714 |
| mus_musculus | Bola2 | ENSMUSG00000047721 |
| rattus_norvegicus | Bola2-ps1 | ENSRNOG00000015333 |
| rattus_norvegicus | AABR07034928.1 | ENSRNOG00000034215 |
| rattus_norvegicus | Bola2 | ENSRNOG00000047988 |
| drosophila_melanogaster | CG33672 | FBGN0061360 |
Paralogs (3): BOLA3 (ENSG00000163170), BOLA2B (ENSG00000169627), BOLA1 (ENSG00000178096)
Protein
Protein identifiers
BolA-like protein 2 — Q9H3K6 (reviewed: Q9H3K6)
All UniProt accessions (2): Q9H3K6, H3BPT9
UniProt curated annotations — full annotation on UniProt →
Function. Acts as a cytosolic iron-sulfur (Fe-S) cluster assembly factor that facilitates [2Fe-2S] cluster insertion into a subset of cytosolic proteins. Acts together with the monothiol glutaredoxin GLRX3.
Subunit / interactions. Interacts with GLRX3; forms a heterotrimeric complex composed by two BOLA2 molecules and one GLRX3 molecule; linked by [2Fe-2S] clusters.
Subcellular location. Cytoplasm. Nucleus.
Miscellaneous. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.
Similarity. Belongs to the BolA/IbaG family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9H3K6-1 | 1 | yes |
| Q9H3K6-2 | 2 |
RefSeq proteins (3): NP_001026997, NP_001307508, NP_001408609 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002634 | BolA | Family |
| IPR036065 | BolA-like_sf | Homologous_superfamily |
| IPR045115 | BOL2 | Family |
Pfam: PF01722
UniProt features (4 total): splice variant 2, chain 1, modified residue 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9H3K6-F1 | 92.72 | 0.83 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 1
Function
Pathways and Gene Ontology
Reactome pathways
6 pathways
| ID | Pathway |
|---|---|
| R-HSA-8950505 | Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation |
| R-HSA-1280215 | Cytokine Signaling in Immune system |
| R-HSA-168256 | Immune System |
| R-HSA-447115 | Interleukin-12 family signaling |
| R-HSA-449147 | Signaling by Interleukins |
| R-HSA-9020591 | Interleukin-12 signaling |
MSigDB gene sets: 110 (showing top):
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10, BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN, RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP, REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM, TTTGTAG_MIR520D, GOBP_INTRACELLULAR_IRON_ION_HOMEOSTASIS, DACOSTA_UV_RESPONSE_VIA_ERCC3_UP, PUJANA_CHEK2_PCC_NETWORK, GOBP_PROTEIN_MATURATION, ONKEN_UVEAL_MELANOMA_UP, GOBP_CELL_REDOX_HOMEOSTASIS, chr16p11, GTGTTGA_MIR505, ATTACAT_MIR3803P, LIAO_METASTASIS
GO Biological Process (5): intracellular iron ion homeostasis (GO:0006879), iron-sulfur cluster assembly (GO:0016226), [2Fe-2S] cluster assembly (GO:0044571), cell redox homeostasis (GO:0045454), protein maturation (GO:0051604)
GO Molecular Function (3): iron-sulfur cluster binding (GO:0051536), 2 iron, 2 sulfur cluster binding (GO:0051537), protein binding (GO:0005515)
GO Cellular Component (4): nucleus (GO:0005634), cytoplasm (GO:0005737), cytosol (GO:0005829), iron-sulfur cluster assembly complex (GO:1990229)
Reactome top-level categories
Rollup of top-5 pathways:
| Category | Pathways |
|---|---|
| Interleukin-12 signaling | 1 |
| Immune System | 1 |
| Signaling by Interleukins | 1 |
| Cytokine Signaling in Immune system | 1 |
| Interleukin-12 family signaling | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| cytoplasm | 2 |
| intracellular monoatomic cation homeostasis | 1 |
| inorganic ion homeostasis | 1 |
| metallo-sulfur cluster assembly | 1 |
| iron-sulfur cluster assembly | 1 |
| cellular homeostasis | 1 |
| gene expression | 1 |
| protein metabolic process | 1 |
| metal cluster binding | 1 |
| iron-sulfur cluster binding | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular anatomical structure | 1 |
| protein-containing complex | 1 |
Protein interactions and networks
STRING
1132 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| BOLA2 | BOLA3 | Q53S33 | 986 |
| BOLA2 | GLRX3 | O76003 | 943 |
| BOLA2 | GLRX5 | Q86SX6 | 746 |
| BOLA2 | CIAPIN1 | Q6FI81 | 717 |
| BOLA2 | NFU1 | Q9UMS0 | 577 |
| BOLA2 | LIAS | O43766 | 543 |
| BOLA2 | NDOR1 | Q9UHB4 | 543 |
| BOLA2 | GPHRA | B7ZAQ6 | 528 |
| BOLA2 | MMS19 | Q96T76 | 518 |
| BOLA2 | BOLA1 | Q9Y3E2 | 517 |
| BOLA2 | SRGAP2C | P0DJJ0 | 502 |
| BOLA2 | ISCA2 | Q86U28 | 497 |
| BOLA2 | GLRX | P35754 | 496 |
| BOLA2 | ISCU | Q9H1K1 | 496 |
| BOLA2 | ARHGAP11B | Q3KRB8 | 479 |
IntAct
90 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CIAPIN1 | GLRX3 | psi-mi:“MI:0914”(association) | 0.960 |
| CFTR | ESYT2 | psi-mi:“MI:2364”(proximity) | 0.710 |
| GLRX3 | KLRG2 | psi-mi:“MI:0914”(association) | 0.640 |
| KLRG2 | GLRX3 | psi-mi:“MI:0914”(association) | 0.640 |
| GLRX3 | BOLA2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| BOLA2 | GLRX3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KLRG2 | GXYLT2 | psi-mi:“MI:0914”(association) | 0.530 |
| VCAM1 | PSMD11 | psi-mi:“MI:0914”(association) | 0.530 |
| CIAPIN1 | BOLA2 | psi-mi:“MI:0915”(physical association) | 0.500 |
| NDOR1 | BOLA2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| BOLA2 | NARF | psi-mi:“MI:0915”(physical association) | 0.400 |
| BOLA2 | SNCA | psi-mi:“MI:0915”(physical association) | 0.400 |
| MAPK6 | psi-mi:“MI:0914”(association) | 0.350 | |
| ARRB2 | psi-mi:“MI:0914”(association) | 0.350 | |
| CDK1 | RBMXL2 | psi-mi:“MI:0914”(association) | 0.350 |
| COQ2 | SNRPGP15 | psi-mi:“MI:0914”(association) | 0.350 |
| COX15 | SNRPGP15 | psi-mi:“MI:0914”(association) | 0.350 |
| DLD | NFKBIE | psi-mi:“MI:0914”(association) | 0.350 |
| DLST | psi-mi:“MI:0914”(association) | 0.350 | |
| PARK7 | SAP18 | psi-mi:“MI:0914”(association) | 0.350 |
| SOAT1 | SNRPGP15 | psi-mi:“MI:0914”(association) | 0.350 |
| VDAC1 | SNRPGP15 | psi-mi:“MI:0914”(association) | 0.350 |
| DLD | EIF3D | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (192): BOLA2 (Affinity Capture-MS), BOLA2 (Affinity Capture-MS), BOLA2 (Affinity Capture-MS), BOLA2 (Affinity Capture-MS), BOLA2B (Affinity Capture-MS), BOLA2 (Affinity Capture-MS), BOLA2B (Affinity Capture-MS), BOLA2 (Affinity Capture-MS), BOLA2B (Affinity Capture-MS), BOLA2 (Affinity Capture-MS), BOLA2B (Affinity Capture-MS), BOLA2 (Affinity Capture-MS), BOLA2B (Affinity Capture-MS), BOLA2 (Affinity Capture-MS), BOLA2B (Affinity Capture-MS)
ESM2 similar proteins: A1A4Q2, A1YER2, A1YFX9, A2T7G9, A6QP05, B0BN93, B0BNF8, B2GV38, O35331, O80526, O95154, O95671, P10950, P11172, P11441, P13439, P21126, P46597, P50053, P84169, Q0VCN1, Q28DS0, Q2HJF1, Q2QNG7, Q2QZ86, Q3T138, Q3TY86, Q5E964, Q5I0K3, Q5R4T1, Q5R514, Q5R8R4, Q5RB44, Q6P637, Q8BGS2, Q8CG45, Q8CG76, Q8CI33, Q8HZJ0, Q8JGT5
Diamond homologs: O14280, P39724, P53082, P91375, Q3SZ84, Q53S33, Q84W65, Q86HT3, Q8BGS2, Q8CEI1, Q9FIC3, Q9H3K6, Q9KPS0, Q9USK1, P0ABE2, P0ABE3, P0ABE4, P43780, P57545, Q12238, Q3E793, Q3T138, Q56585, Q5RCE5, Q682I1, Q86KD0, Q89AA2, Q9D8S9, Q9Y3E2, P29943, P73055, P0A9W6, P0A9W7, P0A9W8, Q9LF68, P45026, Q8K992, A0A1S4BZI5, A0A1S4CB73, A0A2K8FTP3
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| BOLA2 | “form complex” | “BOLA2-GLRX3 iron-sulfur cluster assembly complex” | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 92 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Signaling by high-kinase activity BRAF mutants | 5 | 22.3× | 2e-04 |
| Signaling by FGFR1 in disease | 5 | 20.6× | 2e-04 |
| MAP2K and MAPK activation | 5 | 20.1× | 2e-04 |
| Signaling by moderate kinase activity BRAF mutants | 5 | 17.9× | 3e-04 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | 5 | 17.9× | 3e-04 |
| Signaling downstream of RAS mutants | 5 | 17.9× | 3e-04 |
| Signaling by BRAF and RAF1 fusions | 6 | 14.4× | 2e-04 |
| Regulation of RAS by GAPs | 5 | 13.6× | 7e-04 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
5 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 3 |
| Likely benign | 0 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
522 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 16:29454010:CCTTA:C | donor_loss | 1.0000 |
| 16:29454011:CTTAC:C | donor_loss | 1.0000 |
| 16:29454012:TTACC:T | donor_loss | 1.0000 |
| 16:29454013:TACCT:T | donor_loss | 1.0000 |
| 16:29454014:ACCTG:A | donor_loss | 1.0000 |
| 16:29454015:C:G | donor_loss | 1.0000 |
| 16:29454183:CAACT:C | donor_loss | 1.0000 |
| 16:29454184:AACTC:A | donor_loss | 1.0000 |
| 16:29454185:ACT:A | donor_loss | 1.0000 |
| 16:29454186:CTC:C | donor_loss | 1.0000 |
| 16:29454187:TCA:T | donor_loss | 1.0000 |
| 16:29454188:CAC:C | donor_loss | 1.0000 |
| 16:29454189:A:AC | donor_gain | 1.0000 |
| 16:29454190:C:CC | donor_gain | 1.0000 |
| 16:29454190:CCA:C | donor_gain | 1.0000 |
| 16:29453630:C:A | donor_gain | 0.9900 |
| 16:29454182:TCAAC:T | donor_loss | 0.9900 |
| 16:29454185:A:C | donor_gain | 0.9900 |
| 16:29454186:CTCAC:C | donor_loss | 0.9900 |
| 16:29454190:C:CA | donor_loss | 0.9900 |
| 16:29453652:G:A | donor_gain | 0.9800 |
| 16:29454014:A:AC | donor_gain | 0.9800 |
| 16:29454014:A:C | donor_loss | 0.9800 |
| 16:29454015:C:CC | donor_gain | 0.9800 |
| 16:29454189:AC:A | donor_gain | 0.9800 |
| 16:29454190:CC:C | donor_gain | 0.9800 |
| 16:29454688:GACCC:G | donor_gain | 0.9800 |
| 16:29453648:A:AC | donor_gain | 0.9700 |
| 16:29453649:C:CC | donor_gain | 0.9700 |
| 16:29455012:G:GT | donor_gain | 0.9700 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 42 via entrez): RS1002602928 (16:29455497 C>T), RS1233518527 (16:29455396 A>G,T), RS1344199331 (16:29455475 G>A), RS1422279401 (16:29455683 C>T), RS145372287 (16:29456331 G>A), RS1477888959 (16:29455655 C>T), RS1479644293 (16:29455272 C>T), RS1555480231 (16:29453672 G>A), RS1555480233 (16:29453921 C>G), RS1555480245 (16:29455550 T>A), RS1567288225 (16:29453180 CG>C), RS1567288275 (16:29456388 G>A), RS1567288280 (16:29456955 A>T), RS1596708925 (16:29453357 T>C), RS1596708959 (16:29455144 G>C)
Disease associations
OMIM: gene MIM:613182 | disease phenotypes: MIM:615401
GenCC curated gene-disease
Mondo (1): severe combined immunodeficiency due to CORO1A deficiency (MONDO:0014168)
Orphanet (1): Severe combined immunodeficiency due to CORO1A deficiency (Orphanet:228003)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL5724752 (SINGLE PROTEIN)
Molecules with ChEMBL bioactivity
1 molecules (phase ≥1), by development phase (incl. off-target/promiscuous compounds). Patent mentions across the top 20 by phase: 1,538 (via chembl_molecule»patent_compound — counts attach to the compound, not the gene–compound relationship, so off-target/promiscuous molecules can dominate).
| Molecule | Name | Phase | Patents |
|---|---|---|---|
| CHEMBL1232461 | MOLIBRESIB | 2 | 1,538 |
PharmGKB: 1 entry (VIP=true, CPIC=false)
ChEMBL bioactivities
1 potent at pChembl≥5 of 3 total, top 1 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).
| pChembl | Type | Value | Unit | Molecule |
|---|---|---|---|---|
| 5.00 | IC50 | 1e+04 | nM | MOLIBRESIB |
PubChem BioAssay actives
1 with measured affinity, of 8 total; 1 most potent distinct compounds. Largely complementary to BindingDB; screening values are coarse (µM, 4 dp), so sub-nM hits tie at the floor.
| Compound | Assay | Type | Value | Unit |
|---|---|---|---|---|
| 2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]-N-ethylacetamide | 2178999: Inhibition of BOLA2 (unknown origin) incubated for 1 hr by colloidal coomassie staining based LC-MS/MS analysis | ic50 | 10.0000 | uM |
CTD chemical–gene interactions
22 total (human), top 22 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | affects methylation | 1 |
| ethyl-p-hydroxybenzoate | increases expression | 1 |
| sodium arsenite | affects binding, increases reaction | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | decreases expression, affects cotreatment | 1 |
| ICG 001 | increases expression | 1 |
| bisphenol S | decreases methylation | 1 |
| LDN 193189 | affects cotreatment, decreases expression | 1 |
| Zoledronic Acid | increases expression | 1 |
| Amiodarone | increases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Doxorubicin | increases expression | 1 |
| Enzyme Inhibitors | decreases activity, increases O-linked glycosylation | 1 |
| Hydrogen Peroxide | affects expression | 1 |
| Ivermectin | decreases expression | 1 |
| Ribonucleotides | affects binding | 1 |
| Smoke | decreases expression | 1 |
| Thimerosal | increases expression | 1 |
| Tobacco Smoke Pollution | affects expression | 1 |
| Tretinoin | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| beta-Naphthoflavone | increases expression | 1 |
ChEMBL screening assays
7 unique, capped per target: 7 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL5650994 | Binding | Binding affinity to human BOLA2 incubated for 45 mins by Kinobead based pull down assay | NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family. — ChemMedChem |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): severe combined immunodeficiency due to CORO1A deficiency